The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
|Articles|December 1, 2011
Bankrupt Nutrition 21 Acquired by Investment Group
The company will continue to operate under the Nutrition 21 name.
Advertisement
Nutrition ingredient developer
Under the acquisition, Michael Satow will serve as president and CEO of Nutrition 21, while Phillip will be chairman of the board. Nutrition 21’s portfolio includes the Chromax brand chromium picolinate. The company will continue to operate under the Nutrition 21 name.
Advertisement
Related to this article
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
DolCas Biotech is featuring the turmeric-derived ingredient Curcugen in Mānukora’s Mānuka honey and Numin’s cognitive-support drink.
The company says it will feature studies on vitamin K2, choline, folate, and MSM, along with beverage concepts and a first-time pet corner.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
CoreFX Launches CreaSHLD-IN Shielded Creatine at SupplySide Global 2026
2
Robuvit for Stress & Mood: How Horphag's Caffeine-Free Oak Extract Targets Fatigue at the Cellular Level
3
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
4
Logical Square’s Portfolio Expands with Menopause, Prebiotic, and Extraction Introductions
5